VEGFA and uterine corpus sarcoma: To explore whether the anti-angiogenic effect of E7050 involves the modulation of VEGF expression in multidrug-resistant human uterine sarcoma MES-SA/Dx5 cells, VEGF expression in MES-SA/Dx5 cells in response to E7050 treatment was examined.